MassoudFLégerGC. Pharmacological treatment of Alzheimer disease. Can J Psychiatry. 2011;56(10):579–588.
2.
BallardCKhanZClackH, Nonpharmacological treatment of Alzheimer disease. Can J Psychiatry. 2011;56(10):589–595.
3.
McKhannGMKnopmanDSChertkowH, The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263–269.
4.
AlbertMSDeKoskySTDicksonD, The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–279.
5.
SperlingRAAisenPSBeckettLA, Towards defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:280–292.
6.
BellevilleSClémentFMellahM, Training-related brain plasticity in subjects at risk of developing Alzheimer's disease. Brain. 2011;134(Pt 6):1623–1634.
7.
BallardCGauthierSCorbettA, Alzheimer's disease: Update on epidemiology, pathogenesis, diagnosis, treatment and prevention. Lancet. 2011;377(9770):1019–1031.
8.
Canadian Study on Health and Aging: Study methods and prevalence of dementia. CMAJ. 1994;150(6):899–913.
9.
ChertkowH.Introduction: The Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, 2006. Alzheimers Dement. 2007;3(4):262–265.
10.
GauthierSGarciaASanoM, Priorities for research consortia on Alzheimer's disease. Alzheimers Dement. 2010;6:359–362.
11.
AtriAShaughnessyLWLocascioJJ, Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008;22:209–221.
12.
LopezOLBeckerJTWahedAS, Long-term effects of the concordant use of memantine with cholinesterase inhibition in Alzheimer disease. J Neurol Neurosurg Psychiatry. 2009;80:600–607.
13.
PoirierJGauthierS.Pharmacogenomics and the treatment of sporadic Alzheimer's disease: A decade of progress. Curr Pharmacogenomics Person Med. 2008;6:63–76.